Emerald Mutual Fund Advisers Trust’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.9M | Buy |
1,141,428
+19,542
| +2% | +$289K | 1.03% | 30 |
|
|
2025
Q1 | $20.1M | Buy |
1,121,886
+20,112
| +2% | +$360K | 1.43% | 19 |
|
|
2024
Q4 | $19.2M | Sell |
1,101,774
-83,935
| -7% | -$1.46M | 1.17% | 29 |
|
|
2024
Q3 | $16.6M | Buy |
1,185,709
+244,444
| +26% | +$3.42M | 0.86% | 47 |
|
|
2024
Q2 | $7.74M | Sell |
941,265
-387,116
| -29% | -$3.18M | 0.41% | 85 |
|
|
2024
Q1 | $10.2M | Buy |
1,328,381
+563,778
| +74% | +$4.35M | 0.53% | 79 |
|
|
2023
Q4 | $6.87M | Hold |
764,603
| – | – | 0.36% | 97 |
|
|
2023
Q3 | $6.84M | Buy |
764,603
+235,085
| +44% | +$2.1M | 0.41% | 95 |
|
|
2023
Q2 | $8.13M | Buy |
+529,518
| New | +$8.13M | 0.44% | 89 |
|